Members of the Sackler family, the billionaire owners of Purdue Pharma, reached an agreement to pay up to $6 billion to resolve lawsuits alleging the OxyContin maker helped fuel the opioid epidemic.

The Sackler family will now relinquish control of Purdue Pharma and cease sale of opioids in the U.S. as part of a $7.4 billion settlement.

David Sackler (Raymond's grandson) and Dr. Kathe Sackler (Mortimer's daughter), both former Purdue Board members, recently went public to defend the family's actions, and its name, testifying ...

Forbes Valuation. Forbes values the Sackler family’s net worth at $5.2 billion as of February, based on an estimated $11.2 billion in liquid assets minus the $6 billion they were set to pay in ...

Some members of Congress and attorneys general for about half the states oppose that plan, which includes a requirement for Sackler family members to pay at least $3 billion in addition to giving ...

Members of the Sackler family—who no longer have any affiliation with Purdue Pharma—have previously claimed they “acted lawfully in all respects,” though they’ve acknowledged OxyContin ...

The Sackler family members disputed the $11 billion figure on Monday, saying that half of the money they took from the company was used for tax payments. Purdue, ...

Purdue Pharma announced its settlement with all 55 attorneys general on Monday after longstanding allegations.

Those groups are now joining with Purdue and Sackler family members to defend the plan from appeals from an office of U.S. Department of Justice, eight states, the District of Columbia, some ...

Three executives, none of them Sackler family members, pleaded guilty to deceptive marketing charges in 2007 as part of a $600 million settlement with the Justice Department.

A new website seeking to challenge the so-called “false narratives” about the Sackler family argues that OxyContin represented just 4% of all opioid prescriptions in the U.S. between 1992–2018.